ArticleAnalytical and bioanalytical chemistry2026
A two-step hybridization-capture aptasensor with dithiol-DNA-AuNPs interface for rapid, label-free detection of Mycobacterium tuberculosis H37Rv.
Article in Analytical and bioanalytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The global control of tuberculosis (TB) urgently demands diagnostic tools that are rapid, specific, and amenable to resource-limited settings. Here, we report a novel, label-free aptasensor for Mycobacterium tuberculosis (MTB) H37Rv, which operates on an innovative two-step "pre-incubation & hybridization-capture" strategy, fundamentally departing from conventional competitive displacement designs. First, a high-affinity, in-house selected aptamer specifically complexes with target bacteria in solution. This pre-formed complex is then efficiently captured on a gold interdigitated electrode via hybridization with a short, dithiol-anchored DNA probe, which is pre-assembled with conductive gold nanoparticles (AuNPs) to form a robust sensing interface. This architecture decouples target recognition from signal transduction, enhancing assay robustness. The captured bulky and negatively charged bacterial complex synergistically creates pronounced steric and electrostatic barriers at the interface, drastically impeding charge transfer and generating a measurable frequency shift in a multichannel piezoelectric quartz crystal (MSPQC) system. The sensor demonstrates exceptional specificity, clearly distinguishing H37Rv (ΔF = 116 Hz) from non-target bacteria, including Bacillus Calmette-Guérin (BCG) (ΔF < 30 Hz). It exhibits a wide linear response from 10
Indexed as
Identifiers
41661246What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.